Literature DB >> 23250952

Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37.

Jennifer H Moffatt1, Marina Harper, Ashley Mansell, Bethany Crane, Timothy C Fitzsimons, Roger L Nation, Jian Li, Ben Adler, John D Boyce.   

Abstract

Infections caused by multidrug-resistant Acinetobacter baumannii have emerged as a serious global health problem. We have shown previously that A. baumannii can become resistant to the last-line antibiotic colistin via the loss of lipopolysaccharide (LPS), including the lipid A anchor, from the outer membrane (J. H. Moffatt, M. Harper, P. Harrison, J. D. Hale, E. Vinogradov, T. Seemann, R. Henry, B. Crane, F. St. Michael, A. D. Cox, B. Adler, R. L. Nation, J. Li, and J. D. Boyce, Antimicrob. Agents Chemother. 54:4971-4977, 2010). Here, we show how these LPS-deficient bacteria interact with components of the host innate immune system. LPS-deficient A. baumannii stimulated 2- to 4-fold lower levels of NF-κB activation and tumor necrosis factor alpha (TNF-α) secretion from immortalized murine macrophages, but it still elicited low levels of TNF-α secretion via a Toll-like receptor 2-dependent mechanism. Furthermore, we show that while LPS-deficient A. baumannii was not altered in its resistance to human serum, it showed increased susceptibility to the human antimicrobial peptide LL-37. Thus, LPS-deficient, colistin-resistant A. baumannii shows significantly altered activation of the host innate immune inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250952      PMCID: PMC3584870          DOI: 10.1128/IAI.01362-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Differential roles of TLR2 and TLR4 in the host response to Gram-negative bacteria: lessons from a lipopolysaccharide-deficient mutant of Neisseria meningitidis.

Authors:  R R Ingalls; E Lien; D T Golenbock
Journal:  J Endotoxin Res       Date:  2000

2.  Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant.

Authors:  L Steeghs; H de Cock; E Evers; B Zomer; J Tommassen; P van der Ley
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

3.  Meningitis bacterium is viable without endotoxin.

Authors:  L Steeghs; R den Hartog; A den Boer; B Zomer; P Roholl; P van der Ley
Journal:  Nature       Date:  1998-04-02       Impact factor: 49.962

Review 4.  Complement evasion by bacteria and parasites.

Authors:  K A Joiner
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

5.  Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance.

Authors:  M Hong; S M Payne
Journal:  Mol Microbiol       Date:  1997-05       Impact factor: 3.501

6.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.

Authors:  J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

7.  Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

Authors:  J Turner; Y Cho; N N Dinh; A J Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate.

Authors:  Daxin Peng; Wenzhou Hong; Biswa P Choudhury; Russell W Carlson; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

9.  Lessons from an LPS-deficient Neisseria meningitidis mutant.

Authors:  Peter van der Ley; Liana Steeghs
Journal:  J Endotoxin Res       Date:  2003

10.  Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state.

Authors:  D A Hume; D M Underhill; M J Sweet; A O Ozinsky; F Y Liew; A Aderem
Journal:  BMC Immunol       Date:  2001-10-12       Impact factor: 3.615

View more
  32 in total

Review 1.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

2.  Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.

Authors:  Meritxell García-Quintanilla; Marina R Pulido; Patricia Moreno-Martínez; Reyes Martín-Peña; Rafael López-Rojas; Jerónimo Pachón; Michael J McConnell
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 3.  Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat.

Authors:  William Gustavo Lima; Mara Cristina Alves; Waleska Stephanie Cruz; Magna Cristina Paiva
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-09       Impact factor: 3.267

Review 4.  Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside.

Authors:  Ming-Feng Lin; Chung-Yu Lan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 5.  Expanding the paradigm for the outer membrane: Acinetobacter baumannii in the absence of endotoxin.

Authors:  Matthew Joseph Powers; M Stephen Trent
Journal:  Mol Microbiol       Date:  2017-11-20       Impact factor: 3.501

6.  The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection.

Authors:  Pradeep Bist; Neha Dikshit; Tse Hsien Koh; Alessandra Mortellaro; Thuan Tong Tan; Bindu Sukumaran
Journal:  Infect Immun       Date:  2013-12-23       Impact factor: 3.441

Review 7.  Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity.

Authors:  A M Richards; Y Abu Kwaik; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2014-09-27       Impact factor: 3.563

8.  Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.

Authors:  Patrick M Ketter; M Neal Guentzel; Beverly Schaffer; Maryanne Herzig; Xiaowu Wu; Robbie K Montgomery; Bijaya K Parida; Chriselda G Fedyk; Jieh-Juen Yu; James Jorgensen; James P Chambers; Andrew P Cap; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2014-07-07       Impact factor: 3.441

9.  Phospholipid retention in the absence of asymmetry strengthens the outer membrane permeability barrier to last-resort antibiotics.

Authors:  Matthew J Powers; M Stephen Trent
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-07       Impact factor: 11.205

10.  Diversity within the O-linked protein glycosylation systems of acinetobacter species.

Authors:  Nichollas E Scott; Rachel L Kinsella; Alistair V G Edwards; Martin R Larsen; Sucharita Dutta; Julian Saba; Leonard J Foster; Mario F Feldman
Journal:  Mol Cell Proteomics       Date:  2014-06-10       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.